Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-816-9 | CAS number: 74-86-2
Endpoint summary
Administrative data
Description of key information
There are no data on oral and dermal repeat dose toxicity. Studies are not technically feasible as the substance is a gas at room temperature. The limited data available on a close related substance indicates low toxicity via the inhalation route. It is concluded that there are no adverse effects resulting from repeat dose exposure below the lower explosive limit (LEL) of acetylene (2.5%; 26750 mg/m3).
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral and dermal
There are no data on oral and dermal repeat dose toxicity. Studies are not technically feasible as the substance is a gas at room temperature
Inhalation
In consideration of repeat dose toxicity, it is of note that acetylene is metabolised only to a very small extent (~1% if inhaled volume). A highly reactive ketene intermediate may be formed but very rapidly deactivated to acetic acid and it was estimated that no more than 1% of the inhaled amount of acetylene in humans is metabolised to acetate, a natural product (see section 5.1.1 above for further detail). Some repeat-dose studies at anaesthetic concentrations have been reported for acetylene. Excluding the acute effects associated with exposure to acetylene with its well-known anaesthetic and/or asphyxiant properties, there is no evidence of repeat dose toxicity, even at rather high concentrations leading to the conclusion that there are no repeat dose toxicity effects up to the lower explosive limit (LEL) of acetylene.
Justification for classification or non-classification
Due to lack of exposure via the oral or dermal routes (the substance is a gas at room temperature) and very low toxicity following inhalation exposure of a related substance, acetylene does not warrant classification under CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
